Percutaneous ethanol injection therapy is comparable to radiofrequency ablation in hepatocellular carcinoma smaller than 1.5 cm: A matched case–control comparative analysis

Although percutaneous ethanol injection therapy (PEIT) is best indicated for patients with small hepatocellular carcinoma (HCC), the survival advantage of PEIT needs confirmation in real-world practice. This study was approved by the institutional review board, and the informed consent was waived. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Su Jong, Yoon, Jung-Hwan, Lee, Jeong Min, Lee, Jae Young, Kim, Se Hyung, Cho, Young Youn, Yoo, Jeong-Ju, Lee, Minjong, Lee, Dong Hyeon, Cho, Yuri, Cho, Eun Ju, Lee, Jeong-Hoon, Kim, Yoon Jun, Kim, Chung Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008549/
https://www.ncbi.nlm.nih.gov/pubmed/27583865
http://dx.doi.org/10.1097/MD.0000000000004551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008549/
https://www.ncbi.nlm.nih.gov/pubmed/27583865
http://dx.doi.org/10.1097/MD.0000000000004551

Ejemplares similares